Barclays’s Molecular Data Inc. American Depositary Shares MKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,000
Closed 5631
2022
Q3
$0 Hold
10,000
﹤0.01% 5376
2022
Q2
$6K Buy
+10,000
New +$14.4K ﹤0.01% 4773

Other funds holding MKD

Barclays's MKD Position: Q4 2022 in Review

Barclays sold out of Molecular Data Inc. American Depositary Shares (MKD) in Q4 2022, closing a stake of 10,000 shares.

Barclays first reported a position in MKD in Q2 2022 and held it in 2 quarters. The position peaked at $6K in Q2 2022. 1 fund tracked by Wall St. Rank holds MKD as of Q4 2022.

  • Barclays reported no remaining Molecular Data Inc. American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Barclays sold 10,000 Molecular Data Inc. American Depositary Shares shares in Q4 2022.
  • Barclays first reported a position in Molecular Data Inc. American Depositary Shares in Q2 2022 and held it in 2 quarters.
  • Barclays's Molecular Data Inc. American Depositary Shares position peaked at $6K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Molecular Data Inc. American Depositary Shares as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.